2015
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders
Lo A, Ruiz J, Koenig C, Anderson B, Olson K, Triche E. Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders. Journal Of The Neurological Sciences 2015, 356: 77-82. PMID: 26139339, DOI: 10.1016/j.jns.2015.06.008.Peer-Reviewed Original ResearchConceptsNon-dominant sideMultiple sclerosisMultiple Sclerosis Walking Scale-12Six-Spot Step TestD-EREffects of dalfampridineMinute walk testHole Peg TestRoutine clinical careWalk respondersWalk testGait impairmentAmbulatory personsPeg TestGross dexterityClinical carePotential treatmentScale-12Block TestSclerosisGaitStep testRespondersFurther investigationSignificant improvement
2010
Predictors of Nonadherence to Highly Active Antiretroviral Therapy Among HIV-Infected South Indians in Clinical Care: Implications for Developing Adherence Interventions in Resource-Limited Settings
Venkatesh K, Srikrishnan A, Mayer K, Kumarasamy N, Raminani S, Thamburaj E, Prasad L, Triche E, Solomon S, Safren S. Predictors of Nonadherence to Highly Active Antiretroviral Therapy Among HIV-Infected South Indians in Clinical Care: Implications for Developing Adherence Interventions in Resource-Limited Settings. AIDS Patient Care And STDs 2010, 24: 795-803. PMID: 21091232, PMCID: PMC3011993, DOI: 10.1089/apc.2010.0153.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyAntiretroviral therapyClinical careFirst-line non-nucleoside reverse transcriptase inhibitorLower general health perceptionsMedian CD4 cell countNon-nucleoside reverse transcriptase inhibitorMultivariable logistic regression modelOdds of nonadherenceCD4 cell countModifiable risk factorsPredictors of nonadherenceGeneral health perceptionReverse transcriptase inhibitorSouth Indian menResource limited settingsCross-sectional analysisLogistic regression modelsHAART experienceHAART nonadherenceCD4 cellsOptimal adherenceAdherence interventionsClinic populationRisk factors